# Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

> **NCT06561854** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 318 (estimated)

## Conditions studied

- Multiple Myeloma
- Relapse Multiple Myeloma

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT06561854
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 318 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561854, "Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06561854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*